{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:10:46Z","timestamp":1788361846136,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.xphs.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T02:11:35Z","timestamp":1689214295000},"page":"2790-2798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Tacrolimus-Loaded Cationic Nanoemulsion In-Situ Gel System: In-Vitro Characterization and Performance in a Dry-Eye Rabbit Model"],"prefix":"10.1016","volume":"112","author":[{"given":"Qiuhe","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1459-2321","authenticated-orcid":false,"given":"Li","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2023.05.001_bib0001","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/OPTH.S5555","article-title":"Etiology, prevalence, and treatment of dry eye disease","volume":"3","author":"Gayton","year":"2009","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.xphs.2023.05.001_bib0002","first-page":"71","article-title":"The pathophysiology, diagnosis, and treatment of dry eye disease","volume":"112","author":"Messmer","year":"2015","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.xphs.2023.05.001_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105229","article-title":"Cationic nanoemulsions with prolonged retention time as promising carriers for ophthalmic delivery of tacrolimus","volume":"144","author":"Zhang","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.05.001_bib0004","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00128071-200203060-00002","article-title":"Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis","volume":"3","author":"Reitamo","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.xphs.2023.05.001_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0014-2999(00)00592-6","article-title":"FK506 suppresses neutrophil chemoattractant production by peripheral blood mononuclear cells","volume":"403","author":"Sasakawa","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.xphs.2023.05.001_bib0006","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.clae.2015.04.004","article-title":"Treatment of Sj\u00f6gren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study","volume":"38","author":"Moscovici","year":"2015","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.xphs.2023.05.001_bib0007","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejps.2017.12.017","article-title":"Tacrolimus: an updated review on delivering strategies for multifarious diseases","volume":"114","author":"Dheer","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.05.001_bib0008","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.colsurfb.2017.05.049","article-title":"Proglycosomes: a novel nano-vesicle for ocular delivery of tacrolimus","volume":"157","author":"Garg","year":"2017","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.xphs.2023.05.001_bib0009","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.sjopt.2019.04.001","article-title":"Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East","volume":"33","author":"Fiorentini","year":"2019","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.xphs.2023.05.001_bib0010","first-page":"85","article-title":"Polymeric micelles as a novel carrier for ocular drug delivery - sciencedirect","author":"Zsoy","year":"2019","journal-title":"Nanoarchitect Biomed"},{"key":"10.1016\/j.xphs.2023.05.001_bib0011","article-title":"Positively charged polymeric nanoparticles improve ocular penetration of tacrolimus after topical administration","volume":"60","author":"Castro","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2023.05.001_bib0012","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/bjophthalmol-2013-304453","article-title":"Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement","volume":"98","author":"Fukushima","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xphs.2023.05.001_bib0013","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jconrel.2020.10.025","article-title":"Therapeutic nanoemulsions in ophthalmic drug administration: concept in formulations and characterization techniques for ocular drug delivery","volume":"328","author":"Singh","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2023.05.001_bib0014","article-title":"Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis","volume":"597","author":"Henostroz","year":"2020","journal-title":"Colloids Surf A"},{"key":"10.1016\/j.xphs.2023.05.001_bib0015","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1080\/10717544.2016.1223225","article-title":"Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability","volume":"23","author":"Patel","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2023.05.001_bib0016","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2017.10.031","article-title":"Injectable hydrogels for ophthalmic applications","volume":"268","author":"Wang","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2023.05.001_bib0017","article-title":"Development of thermosensitive in situ gel nanoemulsions for ocular delivery of acyclovir","volume":"55","author":"Mmm","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2023.05.001_bib0018","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3109\/03639045.2015.1137306","article-title":"Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept","volume":"42","author":"Patel","year":"2016","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2023.05.001_bib0019","doi-asserted-by":"crossref","first-page":"e05365","DOI":"10.1016\/j.heliyon.2020.e05365","article-title":"In situ ophthalmic gel forming systems of poloxamer 407 and hydroxypropyl methyl cellulose mixtures for sustained ocular delivery of chloramphenicole: optimization study by factorial design","volume":"6","author":"Kurniawansyah","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.xphs.2023.05.001_bib0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2006.10.014","article-title":"Development and bioavailability assessment of ramipril nanoemulsion formulation","volume":"66","author":"Shafiq","year":"2007","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2023.05.001_bib0021","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2011.03.054","article-title":"Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels","volume":"411","author":"Asasutjarit","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2023.05.001_bib0022","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3109\/03639045.2012.707203","article-title":"Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing","volume":"39","author":"Pathak","year":"2012","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2023.05.001_bib0023","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0378-5173(01)00809-2","article-title":"Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium","volume":"226","author":"Yong","year":"2001","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.05.001_bib0024","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2012.12.049","article-title":"Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits","volume":"443","author":"Tayel","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2023.05.001_bib0025","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejps.2017.05.020","article-title":"The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case","volume":"105","author":"Battistini","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.05.001_bib0026","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1021\/acs.molpharmaceut.6b00445","article-title":"Prolonged ocular retention of mucoadhesive nanoparticle eye drop formulation enables treatment of eye diseases using significantly reduced dosage","volume":"13","author":"Liu","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2023.05.001_bib0027","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijpharm.2019.05.018","article-title":"Cationized hyaluronic acid coated spanlastics for cyclosporine A ocular delivery: prolonged ocular retention, enhanced corneal permeation and improved tear production","volume":"565","author":"Liu","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2023.05.001_bib0028","first-page":"3791","article-title":"Supercritical fluid-mediated liposomes containing cyclosporin A for the treatment of dry eye syndrome in a rabbit model: comparative study with the conventional cyclosporin A emulsion","volume":"9","author":"Karn","year":"2014","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2023.05.001_bib0029","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00003226-199109000-00013","article-title":"Factors responsible for tear ferning","volume":"10","author":"Kogbe","year":"1991","journal-title":"Cornea"},{"key":"10.1016\/j.xphs.2023.05.001_bib0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF01204791","article-title":"Tear mucus ferning in patients with Sj\u00f6gren's syndrome","volume":"87","author":"Vaikoussis","year":"1994","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.xphs.2023.05.001_bib0031","article-title":"In situ gel containing bimatoprost solid lipid nanoparticles for ocular delivery: in-vitro and ex-vivo evaluation","volume":"56","author":"Wadetwar","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2023.05.001_bib0032","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijpharm.2016.04.021","article-title":"Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery","volume":"506","author":"Morsi","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2023.05.001_bib0033","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0168-3659(02)00273-0","article-title":"Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur","volume":"85","author":"Zhang","year":"2002","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2023.05.001_bib0034","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejps.2017.04.013","article-title":"Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide","volume":"104","author":"Morsi","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.05.001_bib0035","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drudis.2012.10.005","article-title":"Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers","volume":"18","author":"Gan","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.xphs.2023.05.001_bib0036","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.colsurfb.2008.04.009","article-title":"Physico-chemical properties and cytotoxicity assessment of PEG-modified liposomes containing human hemoglobin","volume":"65","author":"Centis","year":"2008","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.xphs.2023.05.001_bib0037","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3390\/ijms18071558","article-title":"Surface chemistry interactions of cationorm with films by human meibum and tear film compounds","volume":"18","author":"Georgiev","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xphs.2023.05.001_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120010","article-title":"Development and evaluation of doxycycline niosomal thermoresponsive in situ gel for ophthalmic delivery","volume":"591","author":"Gugleva","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2023.05.001_bib0039","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1208\/s12249-009-9268-4","article-title":"Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride","volume":"10","author":"Ammar","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2023.05.001_bib0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00003088-200140020-00001","article-title":"Bioadhesion: new possibilities for drug administration?","volume":"40","author":"Woodley","year":"2001","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.xphs.2023.05.001_bib0041","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/pharmaceutics10030110","article-title":"Useful in vitro techniques to evaluate the mucoadhesive properties of hyaluronic acid-based ocular delivery systems","volume":"10","author":"Gra\u00e7a","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2023.05.001_bib0042","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.2147\/IJN.S254763","article-title":"Stimulus responsive ocular gentamycin-ferrying chitosan nanoparticles hydrogel: formulation optimization, ocular safety and antibacterial assessment","volume":"15","author":"Alruwaili","year":"2020","journal-title":"Int J Nanomed"},{"issue":"8","key":"10.1016\/j.xphs.2023.05.001_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2019.05.036","article-title":"Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications","volume":"24","author":"Soliman","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.xphs.2023.05.001_bib0044","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jsps.2015.04.003","article-title":"Drug release behavior of polymeric matrix filled in capsule","volume":"24","author":"Phaechamud","year":"2016","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.xphs.2023.05.001_bib0045","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archopht.1978.03910050373015","article-title":"Osmolarity of tear microvolumes in keratoconjunctivitis sicca","volume":"96","author":"Gilbard","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xphs.2023.05.001_bib0046","article-title":"The distribution of conjunctival goblet cells in mice","volume":"234","author":"Welss","year":"2020","journal-title":"Ann Anat"},{"key":"10.1016\/j.xphs.2023.05.001_bib0047","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.preteyeres.2016.04.005","article-title":"Goblet cells of the conjunctiva: a review of recent findings","volume":"54","author":"Gipson","year":"2016","journal-title":"Prog Retin Eye Res"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923001892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923001892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:45:16Z","timestamp":1758361516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923001892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0022354923001892"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.05.001","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tacrolimus-Loaded Cationic Nanoemulsion In-Situ Gel System: In-Vitro Characterization and Performance in a Dry-Eye Rabbit Model","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}